Khasiat dan Keamanan Kapsul Ekstrak Daun Salam, Sambiloto, Kayu Manis dan Temulawak sebagai Jamu Antihiperglikemia: Studi Klinis dengan Desain Paralel, Random, dan Tersamar Tunggal

Ulfa Fitriani, Agus Triyono, Zuraida Zulkarnain, Danang Ardiyanto, Fajar Novianto, Ulfatun Nisa, Peristiwan R. W. Astana, Tyas F. Dewi

Abstract


Penyakit diabetes merupakan penyakit non-infeksi yang menjadi perhatian dunia. Penggunaan tanaman obat sebagai terapi diabetes banyak dijumpai. Penelitian sebelumnya terhadap rebusan ramuan jamu antihiperglikemia yang mengandung daun salam, sambiloto, kayu manis dan temulawak terbukti efektif menurunkan kadar gula darah puasa (GDP). Sediaan jamu dalam bentuk kapsul ekstrak diketahui lebih stabil dibanding rebusan. Penelitian ini bertujuan untuk mengetahui kesetaraan kemanfaatan dan keamanan antara kapsul ekstrak jamu antihiperglikemia dengan obat standar metformin dosis tunggal. Metode penelitian ini adalah studi klinik dengan desain paralel, random, dan tersamar tunggal terhadap 60 subjek di Rumah Riset Jamu (RRJ) Hortus Medicus yang telah memenuhi kriteria inklusi dan esklusi pada bulan September hingga November 2019. Intervensi penelitian dilakukan selama 28 hari pada pasien yang menerima kapsul ekstrak (n=30) dan metformin (n=30). Parameter keberhasilan yaitu apabila terjadi penurunan kadar GDP pada pasien serta kadar fungsi hati (Serum Glutamic Oxaloacetic Transaminase/SGOT dan Serum Glutamic Pyruvic Transaminase/SGPT) dan fungsi ginjal (ureum dan kreatinin) tetap berada pada rentang nilai normal. Hasil penelitian menunjukkan rata-rata kadar GDP pada kelompok kapsul ekstrak meningkat dari 165,53+33,28 menjadi 168,17+56,47 dan pada kelompok metformin rata-rata kadar gula darah puasa meningkat dari 161,07+33,00 menjadi 165,20+65,67. Sementara itu, kadar SGOT (17,40+5,35), SGPT (27,10+11,83), ureum (29,57+6,77), dan kreatinin (0,99+0,27) setelah intervensi masih dalam rentang normal. Simpulan dari penelitian ini adalah kaspul ekstrak jamu antihiperglikemia tergolong aman, namun tidak dapat menurunkan GDP. Tidak ditemukan perbedaan yang bermakna antara kelompok kapsul ekstrak dengan metformin.

Kata kunci: Kapsul ekstrak jamu antihiperglikemia, keamanan, khasiat

 

Efficacy and Safety of Extract Capsul of Daun Salam, Sambiloto, Kayu Manis and Temulawak as Antihyperglycemic Herbs: A Randomized, Parallel and Single Mask Design Clinical Study

Abstract

Diabetes mellitus is one of the non infectious disease concerns over the world. Numerous medicinal plants have been used for diabetes. Clinical study of decoction of antihyperglycemic herbs containing daun salam, sambiloto, kayu manis and temulawak has been proven to be effective in reducing fasting blood glucose. Herbal capsule is considered more stable than decoctions. This study aimed to assess the equal efficacy and safety of extract capsule of antihyperglicemia herbs and single dose metformin. We performed clinical study with paralel and single mask design among 60 included patients in Rumah Riset Jamu (RRJ) Hortus Medicus between September and November 2019. Subjects received extract capsul (n=30) versus metformin (n=30) for 28 days. The outcome measure was decrease in fasting blood glucose and the value of liver function (Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT)) and also renal function (ureum and creatinine) at normal range. The results indicated increased fasting blood glucose with the mean values in exctract capsules group from  165,53+33,28 to 168,17+56,47 and metformin group from 161,07+33,00 to 165,20+65,67. Meanwhile, after 28 days intervention, the values of SGOT (17,40+5,35), SGPT (27,10+11,83), ureum (29,57+6,77) dan creatinine (0,99+0,27) showed in the normal range. This study concluded that exctract capsul of antihyperglycemic herbs was safe but did not decrease fasting blood glucose value. No statistical difference was observed between the groups.

Keywords: Efficacy, extract capsul of antihyperglycemic herbs, safety


Keywords


Kapsul ekstrak jamu antihiperglikemia; keamanan; khasiat

References


Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, et al. Long term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: A 3 year prospective, controlled, observational study (J-BRAND Registry). BMJ Open Diabetes Res Care. 2021;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787

Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: An overview of mechanisms of action and clinical implications. Diabetol Metab Syndr. 2017;9:59. doi: 10.1186/s13098-017-0254-9

Inzucchi SE, Docherty KF, Køber, L, Kosiborod MN, Martinez FA, Ponikowski P, et al. Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: An exploratory analysis from DAPA-HF. Diabetes Care. 2021;44(2):586–94. doi: 10.2337/dc20-1675

Ogurtsova K, Rocha JD, Huang Y, Linnenkamp U, Guariguata L. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843

Marín-peñalver JJ, Martín-timón I, Sevillano-collantes C, Cañizo-gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016;7(17):354–395. doi: 10.4239/wjd.v7.i17.354

Zaccardi F, Kloecker DE, Buse JB, Mathieu C, Khunti K, Davies MJ. Use of metformin and cardiovascular effects of new classes of glucose- lowering agents: A meta-analysis of cardiovascular outcome trials in type 2 diabetes. Diabetes Care. 2021;44(2):e32–4. doi: 10.2337/dc20-2080

Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program outcomes study. J Clin Endocrinol Metab. 2016;101(4):1754–61. doi: 10.1210/jc.2015-3754

Verma S, Gupta M, Popli H, Aggarwal G. Diabetes mellitus treatment using herbal drugs. Int J Phytomedicine. 2018;10(1):1–10. doi: 10.5138/09750185.2181

Tim Peneliti Balai Besar Penelitian dan Pengembangan Tanaman Obat dan Obat Tradisional. Sebelas ramuan jamu saintifik pemanfaatan mandiri oleh masyarakat. Tawangmangu: Balai Besar Penelitian dan Pengembangan Tanaman Obat dan Obat Tradisional, Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan; 2019.

Astana PRW, Ardiyanto D, Triyono A, Zulkarnain Z, Novianto F, Nisa U, et al. Laporan penelitian uji klinik RCT ramuan jamu hiperglikemia. Tawangmangu: Balai Besar Penelitian dan Pengembangan Tanaman Obat dan Obat Tradisional, Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan; 2015.

Novianto F, Triyono A. Studi klinis formula jamu antihiperglikemia terhadap fungsi hati. Prosiding Seminar Nasional “Peluang Herbal Sebagai Alternative Medicine”; 2015 September; Semarang, Indonesia. Indonesia: Universitas Wahid Hasyim; 2015.

Kumadoh D, Ofori-kwakye K. Dosage forms of herbal medicinal products and their stability considerations-An overview. J Crit Rev. 2017;January:4–8. doi: 10.22159/JCR.2017V4I4.16077

Lwanga SK, Lameshow S, World Health Organization. Sample size determination in health studies: A practical manual. World Health Organization; 1991.

Dewi TF, Ardiyanto D, Wijaya NR. Skrining fitokimia dan penetapan kadar total flavonoid dan fenol ekstrak air ramuan jamu saintifik diabetes mellitus dan osteoarthritis. Prosiding Seminar Nasional Tumbuhan Obat Indonesia ke-55; 2019 Oktober 17–18; Magelang, Indonesia. Indonesia: LPPM-PMP Universitas Tidar; 2019.

Trisnawati SK, Setyorogo S. Faktor risiko kejadian diabetes melitus tipe ii di Puskesmas Kecamatan Cengkareng Jakarta Barat Tahun 2012. J Ilmiah Kesehatan. 2013;5(1):6–11.

Mihardja L, Soetrisno U, Soegondo S. Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians. J Diabetes Investig. 2014;5(5):507–12. doi: 10.1111/jdi.12177

Hasan A, Ul-haq Z, Fazid S, Hussain B, Raza A, Jawa A. et al. Type 2 diabetes prevalence in Pakistan: What is driving this ? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of Pakistan. Cardiovasc Endocrinol Metab. 2020;9(4):159–64. doi: 10.1097/XCE.0000000000000212

Karimah HN, Agung IG, Habibah N. Gambaran kadar HbA1C pada pasien diabetes melitus tipe 2 di RSUD Wangaya. Meditory. 2018;6(2):88–98. doi: 10.33992/m.v6i2.442

Wahyuningrum R, Wahyono D, Mustofa, Prabandari YS. Masalah-masalah terkait pengobatan diabetes melitus tipe 2 : sebuah studi kualitatif medication-related problems in patients with type 2 diabetes mellitus: A qualitative study. Indones J Clin Pharm. 2020;9:26–42.

Jeon JY, Lee SJ, Lee S, Kim SJ, Han SJ, Kim HJ, et al. Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program. J Diabetes Investig. 2018;9(5):1144–52.

Desrita, DP. Pengaruh metode perebusan terhadap uji fitokimia daun mangrove Excoecaria agallocha. J Penelitian Pendidikan Sosial Humaniora. 2018;3(2):424–48. doi: 10.32696/jp2sh.v3i2.231

Altemimi A, Lakhssassi N, Baharlouei A, Watson DG. Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants. 2017;6(4):42. doi: 10.3390/plants6040042

Jayakumar T, Hsieh CY, Lee JJ, Sheu JR. Experimental and clinical pharmacology of andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med. 2013;2013:846740. doi: 10.1155/2013/846740.

Su H, Mo J, Ni J, Ke H, Bao T, Xie J, et al. Andrographolide exerts antihyperglycemic effect through strengthening intestinal barrier function and increasing microbial composition of Akkermansia muciniphila. Oxid Med Cell Longev. 2020;2020:6538930. doi: 10.1155/2020/6538930

Rissa MM. Mekanisme ekstrak daun salam (Syzygium polyanthum) sebagai Antidiabetes. J Health Sains. 2022;33(2):1–12. doi: 10.46799/jhs.v3i2.421

A

ryaeian N, Sedehi SK, Arablou T. Polyphenols and their effects on diabetes management: A review. Med J Islam Repub Iran. 2017;31:134. doi: 10.14196/mjiri.31.134

Purbowatingrum, Ngadiwiyana, Fachriyah E, Ismiyarto, Ariestiani B, Khikmah. Antidiabetic activity from cinnamaldydhe encapsulated by nanochitosan. IOP Conf Series: Mater Sci Eng. 2018;349:012048. doi:10.1088/1757-899X/349/1/012048

Suryanti V, Wibowo FR, Khotijah S, Andalucki N. Antioxidant activities of cinnamaldehyde derivatives. IOP Conf Series: Mater Sci Eng. 2018;333:012077. doi:10.1088/1757-899X/333/1/012077

Nurinda E, Kusumawardani N, Nurinda E. Correlation between the antioxidant capacity of plasma and blood glucose level. Pharm Edu. 2021;21(2):108–15. doi: 10.46542/pe.2021.212.108115



Digital Object Identifier

DOI : https://doi.org/10.15416/ijcp.2022.11.3.187


Dimension Citation Metrics Badge

Refbacks

  • There are currently no refbacks.


 Indonesian Journal of Clinical Pharmacy is indexed by

        

  Creative Commons License

IJCP by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 

View My Stats